Header Logo

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma.

Mathew Thomas V, Bindal P, Vredenburgh JJ. Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma. Case Rep Oncol. 2019 Jan-Apr; 12(1):126-130.

View in: PubMed